In response to: Treatment of patients with multiple myeloma progressing on frontline therapy with lenalidomide, Moreau et al., 2019

Blood Cancer J. 2019 Nov 19;9(12):89. doi: 10.1038/s41408-019-0250-4.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Bortezomib
  • Humans
  • Lenalidomide
  • Multiple Myeloma*
  • Thalidomide

Substances

  • Thalidomide
  • Bortezomib
  • Lenalidomide